Katrina Goddard, PhD

Senior Investigator
Katrina Goddard

Katrina Goddard, PhD, is a genetic epidemiologist who focuses on public health genomics and the translation of genetic testing into practice. She joined the Center for Health Research in 2007.

Dr. Goddard is the principal investigator of a study funded by the National Human Genome Research Institute (NHGRI) that is exploring how to use a new technology—whole genome sequencing—in everyday clinical practice. The study will test would-be parents before they conceive for genetic mutations that could cause rare but serious diseases in their children. The study will compare couples who get usual care to couples who get tested with whole genome sequencing, and will explore how to implement such testing in a health plan.

Dr. Goddard is director of the NW Biobank, a repository of blood and tissue samples linked to health plan members’ comprehensive electronic medical records. The biobank enables researchers to connect people’s genetic information with their health care, including vital signs, diagnoses and treatments.

Recently, Dr. Goddard was the co-principal investigator on a large comparative effectiveness research project in genomic and personalized medicine for colon cancer (CERGEN). She has worked on identifying genetic risk factors for various diseases, such as prostate cancer, esophageal cancer, Alzheimer’s disease, and others, and has been involved in the evaluation of commercial genetic testing. She worked on a multicenter study to map genes for Fuchs’ dystrophy, and served as principal investigator of the Tools for Analysis of Whole-Genome Association in Cystic Fibrosis project. Dr. Goddard recently completed a one-year fellowship in the National Office of Public Health Genomics under the direction of Muin Khoury, which was jointly sponsored by the Centers for Disease Control and the American Society of Human Genetics.

Prior to her appointment as a Senior Investigator, Dr. Goddard was on the faculty at Case Western Reserve University in the Division of Genetic & Molecular Epidemiology, directed by Dr. Robert Elston. At Case Western, she was involved in several large-scale gene-discovery projects, and was the associate director of the Human Genetic Analysis Resource, which produces the SAGE software package. She received her PhD in biostatistics from the University of Washington in 1999, and a BS in Molecular Biology from the University of Wisconsin-Madison.

E-mail: Katrina.AB.Goddard@kpchr.org

Back to Investigators »

Recent Publications

Feigelson HS, Zeng C, Pawloski PA, Onitilo AA, Richards CS, Johnson MA, Kauffman TL, Webster J, Niyirenda C, Alexander GL, Hwang C, Cross D, McCarty CA, Davis RL, Schwarzkopf D, Williams AE, Honda S, Daida Y, Kushi LH, Delate T, Goddard KAB on behalf of the CERGEN Study Team. Does KRAS testing in metastatic colorectal cancer impact overall survival? A comparative effectiveness study in a population-based sample. PLoS One. 2014 May 1;9(5):e94977. doi: 10.1371/journal.pone.0094977. eCollection 2014.   Full text
Musser ED, Hawkey E, Kachan-Liu SS, Lees, P, Roullet J, Goddard K, Steiner RD, Nigg JT. Shared familial transmission of autism spectrum and attention-deficit/hyperactivity disorders. J Child Psychol Psychiatry. 2014 Jan 21. doi: 10.1111/jcpp.12201. [Epub ahead of print]   PubMed abstract
Cross D, Rahm A.K., Kauffman T, Webster J, Le A, Fiegelson HS, Alexander G, Meier P, Onitilo, A, Pawloski P, Williams A, Honda S, Daida, Y, McCarty C, Goddard K. Underutilization of Lynch syndrome screening in a multisite study of patients with colorectal cancer. Genetics in Medicine. 2013 May 2. doi: 10.1038/gim.2013.43. [Epub ahead of print]   PubMed abstract
Goddard KA, Whitlock EP, Berg JS, Williams MS, Webber EM, Webster JA, Lin JS, Schrader KA, Campos-Outcalt D, Offit K, Feigelson HS, Hollombe C. Description and pilot results from a novel method for evaluating return of incidental findings from next-generation sequencing technologies. Genet Med. 2013 Sep;15(9):721-8. [Epub 2013 Apr 4]   Full text
Goddard KA, Whitlock EP, Berg JS, Williams MS, Webber EM, Webster JA, Lin JS, Schrader KA, Campos-Outcalt D, Offit K, Feigelson HS, Hollombe C. Description and pilot results from a novel method for evaluating return of incidental findings from next-generation sequencing technologies. Genetics in Medicine 2013 Sep;15(9):721-8. [Epub 2013 Apr 4]   PubMed abstract
Harris JN, Liljestrand P, Alexander GL, Goddard KA, Kauffman T, Koleveska T, McCarty C, O'Neill S, Pawloski P, Rahm A, Williams A, Somkin CP. Oncologists’ attitudes towards KRAS testing: a multi-site study. Cancer Med. 2013 Dec;2(6):881-8. [Epub 2013 Oct 2.]   PubMed abstract
Khoury MJ, Lam TK, Ioannidis JPA, Hartge P, Spitz MR, Buring JE, Chanock SJ, Croyle RT, Goddard KA, Ginsburg GS, Herceg Z, Hiatt RA, Hoover RN, Hunter DJ, Kramer BS, Lauer MS, Meyerhardt JA, Olopade OI, Palmer JR, Sellers TA, Seminara D, Ransohoff DF, Rebbeck TR, Tourassi G, Winn DM, Zauber A, Schully SD. Transforming epidemiology for 21st century medicine and public health. Cancer Epidemiol Biomarkers Prev. 2013 Apr;22(4):508-16. doi: 10.1158/1055-9965.EPI-13-0146. Epub 2013 Mar 5. PMCID: PMC3625652   Full text
Simonds NI, Khoury MJ, Schully SD, Armstrong K, Cohn W, Fenstermacher D, Ginsburg GS, Goddard KAB, Knaus W, Lyman GH, Ramsey SD, Xu J, Freedman AN. Comparative effectiveness research in cancer genomics and precision medicine: current landscape and future prospects. Journal of the National Cancer Institute 2013 Jul 3; 105(13):929-936. PMCID:PMC3699435 [Available on 2014/7/3]   Full text
Thameem F1, Igo RP Jr2, Freedman BI3, Langefeld C3, Hanson RL4, Schelling JR5, Elston RC2, Duggirala R6, Nicholas SB7, Goddard KA8, Divers J3, Guo X9, Ipp E10, Kimmel PL11, Meoni LA12, Shah VO13, Smith MW14, Winkler CA15, Zager PG13, Knowler WC4, Nelson RG4, Pahl MV16, Parekh RS17, Kao WH12, Rasooly RS11, Adler SG10, Abboud HE1, Iyengar SK2, Sedor JR2; Family Investigation of Nephropathy and Diabetes Research Group. A Genome-Wide Search for Linkage of Estimated Glomerular Filtration Rate (eGFR) in the Family Investigation of Nephropathy and Diabetes (FIND). PLoS One. 2013 Dec 17;8(12):e81888.   Full text
Webster J, Kauffman T, Feigelson HS, Pawloski P, Onitilo AA, Potosky AL, Cross D, Meier P, Mirabedi AS, Delate T, Daida Y, Williams A, Alexander GL, McCarty CA, Honda S, Kushi L, Goddard KAB; on behalf of the CERGEN study team. KRAS testing and epidermal growth factor receptor inhibitor treatment for colorectal cancer in community settings. Cancer Epidemiology, Biomarkers & Prevention 2013 Jan; 22(1):91-101. [Epub 2012 Nov 15] PMCID: PMC3567775 [Available on 2014/1/1]   Full text


More Publications »
Kaiser Permanente